DEXCOM INC — Director's Dealing 2020

Jan 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-01-09

Reporting Person: Murphy Patrick Michael (SVP, Legal Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-09	Common Stock	S	500	$235.01	Disposed	26947	Direct

Footnotes

F1: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020.